Artículos del autor

solaci

Femoropopliteal

TCT 2018 | IMPERIAL: First Study Comparing Drug-Eluting Stents in Patients with Femoropopliteal Disease

The IMPERIAL trial compared the safety and efficacy of a nitinol self-expanding polymer-free placlitaxel-eluting stent (Zilver PTX,...
solaci -
International Congresses

TCT 2018

Here you will find the highlights of the TCT 2018, held on September 21-25 in the city...
solaci -
Structural heart disease

New Atrial Fibrillation After TAVR Indicates Prognosis

Courtesy of Dr. Carlos Fava. Transcatheter aortic valve replacement (TAVR) has emerged as an important treatment alternative for intermediate-...
solaci -
Mitral valve

Mitral Valve Repair in Patients with Cardiac Failure

The mitral valve is a complex apparatus dependent on left atrium and left ventricle functionality. Dilation of...
solaci -
Pharmacology

What to Do with Blood Pressure Levels Between 130/80 and 139/89 mmHg

The decision to be made with a treatment-free patient with systolic blood pressure over 160 mmHg or diastolic...
solaci -
Structural heart disease

Aortic Stenosis with Normal Flow Low Gradient: Should We Intervene or Wait?

Symptomatic patients with <1 cm² aortic valve area will benefit from an intervention regardless parameters such as...
solaci -
Pharmacology

Ten Commandments of the European Hypertension Guidelines: Several “Sins Allowed” Compared with American Guidelines

These new hypertension guidelines (which were as long-awaited as the American ones, back then) finally emerged in...
solaci -
Structural heart disease

TAVR Post-dilation Is Safe

Courtesy of Dr. Carlos Fava. Numerous studies have shown that the presence of aortic regurgitation after TAVR is...
solaci -